Table 2. Patient Characteristics.
HPV, Human Papillomavirus
| N = 47 | % | |
| Age at Diagnosis | ||
| <50 years | 5 | 10.6 |
| >= 50 and <60 years | 15 | 31.9 |
| >=60 and <70 years | 19 | 40.4 |
| >=70 years | 8 | 17.0 |
| Gender | ||
| Male | 39 | 83.0 |
| Female | 8 | 17.0 |
| Primary Tumor Site | ||
| Oropharynx | 40 | 85.1 |
| Oral Cavity | 3 | 6.38 |
| Larynx | 2 | 4.26 |
| Nasopharyngeal | 1 | 2.13 |
| Unknown | 1 | 2.13 |
| Stage | ||
| Localized | 19 | 40.0 |
| Locally Advanced | 28 | 60.0 |
| Treatment Modality | ||
| Definitive Radiation | 4 | 8.51 |
| Definitive Chemoradiation | 35 | 74.5 |
| Postoperative Radiation | 2 | 4.26 |
| Postoperative Chemoradiation | 6 | 12.8 |
| HPV Status | ||
| Positive | 37 | 78.7 |
| Negative | 5 | 10.6 |
| Unknown | 5 | 10.6 |